Ishihara, H. ., Takagi, T. ., Kondo, T. ., Tachibana, H. ., Yoshida, K. ., Omae, K. ., … Tanabe, K. . (2018). Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-018-1241-3 (Original work published 2018)